Virulence factors of Trypanosoma cruzi: Who is who?

Microbes and Infection

Volumn 14, Issue 15, 2012, Pages 1390-1402

  Osorio, Luis ^a   Ríos, Isabel ^a   Gutiérrez, Bessy ^a   González, Jorge ^a  

^a UNIVERSIDAD DE ANTOFAGASTA   (Chile)

Author keywords

Enzymes; Glycoproteins; Trypanosoma cruzi; Virulence factors

Indexed keywords

CALCINEURIN; CALPAIN; COMPLEMENT COMPONENT C2; CRUZIPAIN; DECAY ACCELERATING FACTOR; GLYCOSYLPHOSPHATIDYLINOSITOL DIACYLGLYCEROL LYASE; MUCIN; PHOSPHOLIPASE A1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEASOME; VIRULENCE FACTOR;

ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; CELL VACUOLE; DETOXIFICATION; HOST CELL; IMMUNE EVASION; IMMUNE RESPONSE; LIFE CYCLE; NONHUMAN; OXIDATIVE STRESS; PARASITE SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; HOST-PARASITE INTERACTIONS; HUMANS; LIFE CYCLE STAGES; TRYPANOSOMA CRUZI; VIRULENCE FACTORS;

MAMMALIA; TRYPANOSOMA CRUZI;

EID: 84870796036     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.09.003     Document Type: Article

References (106)

1. Andrade L.O., Andrews N.W. The Trypanosoma cruzi-host-cell interplay: location, invasion, retention. Nat. Rev. Microbiol. 2005, 3:819-823.
2. Anderson R.M., May R.M. Coevolution of hosts and parasites. Parasitology 1982, 85:411-426.
3. Brown S.P., Cornforth D.M., Mideo N. Evolution of virulence in opportunistic pathogens: generalism, plasticity, and control. Trends Microbiol. 2012, 20:336-342.
4. Miles M.A., Llewellyn M.S., Lewis M.D., Yeo M., Baleela R., Fitzpatrick S., Gaunt M.W., Mauricio I.L. The molecular epidemiology and phylogeography of Trypanosoma cruzi and parallel research on Leishmania: looking back and to the future. Parasitology 2009, 136:1509-1528.
5. Brisse S., Barnabe C., Banuls A.L., Sidibe I., Noel S., Tibayrenc M. A phylogenetic analysis of the Trypanosoma cruzi genome project CL Brener reference strain by multilocus enzyme electrophoresis and multiprimer random amplified polymorphic DNA fingerprinting. Mol. Biochem. Parasitol. 1998, 92:253-263.
6. Perez Brandan C., Padilla A.M., Diosque P., Basombrio M.A. Trypanosoma cruzi: infectivity modulation of a clone after passages through different hosts. Exp. Parasitol. 2006, 114:89-93.
7. Yoshida N. Molecular basis of mammalian cell invasion by Trypanosoma cruzi. An. Acad. Bras. Cienc. 2006, 78:87-111.
8. Epting C.L., Coates B.M., Engman D.M. Molecular mechanisms of host cell invasion by Trypanosoma cruzi. Exp. Parasitol. 2010, 126:283-291.
9. Irigoin F., Cibils L., Comini M.A., Wilkinson S.R., Flohe L., Radi R. Insights into the redox biology of Trypanosoma cruzi: trypanothione metabolism and oxidant detoxification. Free Radic. Biol. Med. 2008, 45:733-742.
10. Alvarez M.N., Piacenza L., Irigoin F., Peluffo G., Radi R. Macrophage-derived peroxynitrite diffusion and toxicity to Trypanosoma cruzi. Arch. Biochem. Biophys. 2004, 432:222-232.
11. Alvarez M.N., Peluffo G., Piacenza L., Radi R. Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi: consequences for oxidative killing and role of microbial peroxiredoxins in infectivity. J. Biol. Chem. 2011, 286:6627-6640.
12. Piacenza L., Peluffo G., Alvarez M.N., Kelly J.M., Wilkinson S.R., Radi R. Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage- and endogenously-derived peroxynitrite. Biochem. J. 2008, 410:359-368.
13. Piacenza L., Zago M.P., Peluffo G., Alvarez M.N., Basombrio M.A., Radi R. Enzymes of the antioxidant network as novel determiners of Trypanosoma cruzi virulence. Int. J. Parasitol. 2009, 39:1455-1464.
14. Wilkinson S.R., Obado S.O., Mauricio I.L., Kelly J.M. Trypanosoma cruzi expresses a plant-like ascorbate-dependent hemoperoxidase localized to the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:13453-13458.
15. Mateo H., Marin C., Perez-Cordon G., Sanchez-Moreno M. Purification and biochemical characterization of four iron superoxide dismutases in Trypanosoma cruzi. Mem. Inst. Oswaldo Cruz 2008, 103:271-276.
16. Parodi-Talice A., Monteiro-Goes V., Arrambide N., Avila A.R., Duran R., Correa A., Dallagiovanna B., Cayota A., Krieger M., Goldenberg S., Robello C. Proteomic analysis of metacyclic trypomastigotes undergoing Trypanosoma cruzi metacyclogenesis. J. Mass. Spectrom. 2007, 42:1422-1432.
17. Kipnis T.L., David J.R., Alper C.A., Sher A., da Silva W.D. Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:602-605.
18. Norris K.A., Bradt B., Cooper N.R., So M. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor. J. Immunol. 1991, 147:2240-2247.
19. Tambourgi D.V., Kipnis T.L., da Silva W.D., Joiner K.A., Sher A., Heath S., Hall B.F., Ogden G.B. A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF. Infect. Immun. 1993, 61:3656-3663.
20. Norris K.A. Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance. Infect. Immun. 1998, 66:2460-2465.
21. Beucher M., Norris K.A. Sequence diversity of the Trypanosoma cruzi complement regulatory protein family. Infect. Immun. 2008, 76:750-758.
22. Cestari Idos S., Krarup A., Sim R.B., Inal J.M., Ramirez M.I. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi. Mol. Immunol. 2009, 47:426-437.
23. Cestari Idos S., Evans-Osses I., Freitas J.C., Inal J.M., Ramirez M.I. Complement C2 receptor inhibitor trispanning confers an increased ability to resist complement-mediated lysis in Trypanosoma cruzi. J. Infect. Dis. 2008, 198:1276-1283.
24. Blom A.M., Hallstrom T., Riesbeck K. Complement evasion strategies of pathogens-acquisition of inhibitors and beyond. Mol. Immunol. 2009, 46:2808-2817.
25. Valck C., Ramirez G., Lopez N., Ribeiro C.H., Maldonado I., Sanchez G., Ferreira V.P., Schwaeble W., Ferreira A. Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin. Mol. Immunol. 2010, 47:1516-1521.
26. Ramirez G., Valck C., Molina M.C., Ribeiro C.H., Lopez N., Sanchez G., Ferreira V.P., Billetta R., Aguilar L., Maldonado I., Cattan P., Schwaeble W., Ferreira A. Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity. Immunobiology 2011, 216:265-273.
27. Reina-San-Martin B., Degrave W., Rougeot C., Cosson A., Chamond N., Cordeiro-Da-Silva A., Arala-Chaves M., Coutinho A., Minoprio P. A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat. Med. 2000, 6:890-897.
28. Chamond N., Gregoire C., Coatnoan N., Rougeot C., Freitas-Junior L.H., da Silveira J.F., Degrave W.M., Minoprio P. Biochemical characterization of proline racemases from the human protozoan parasite Trypanosoma cruzi and definition of putative protein signatures. J. Biol. Chem. 2003, 278:15484-15494.
29. Chamond N., Goytia M., Coatnoan N., Barale J.C., Cosson A., Degrave W.M., Minoprio P. Trypanosoma cruzi proline racemases are involved in parasite differentiation and infectivity. Mol. Microbiol. 2005, 58:46-60.
30. Coutinho L., Ferreira M.A., Cosson A., Batista M.M., Batista Dda G., Minoprio P., Degrave W.M., Berneman A., Soeiro Mde N. Inhibition of Trypanosoma cruzi proline racemase affects host-parasite interactions and the outcome of in vitro infection. Mem. Inst. Oswaldo Cruz 2009, 104:1055-1062.
31. Ouaissi M.A., Dubremetz J.F., Schoneck R., Fernandez-Gomez R., Gomez-Corvera R., Billaut-Mulot O., Taibi A., Loyens M., Tartar A., Sergheraert C., et al. Trypanosoma cruzi: a 52-kDa protein sharing sequence homology with glutathione S-transferase is localized in parasite organelles morphologically resembling reservosomes. Exp. Parasitol. 1995, 81:453-461.
32. Allaoui A., Francois C., Zemzoumi K., Guilvard E., Ouaissi A. Intracellular growth and metacyclogenesis defects in Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele. Mol. Microbiol. 1999, 32:1273-1286.
33. Ouaissi A., Guilvard E., Delneste Y., Caron G., Magistrelli G., Herbault N., Thieblemont N., Jeannin P. The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via toll-like receptor 2, and confers protection against lethal infection. J. Immunol. 2002, 168:6366-6374.
34. Fernandez-Gomez R., Esteban S., Gomez-Corvera R., Zoulika K., Ouaissi A. Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages. J. Immunol. 1998, 160:3471-3479.
35. Cestari I., Ansa-Addo E., Deolindo P., Inal J.M., Ramirez M.I. Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles. J. Immunol. 2012, 188:1942-1952.
36. Ramirez M.I., Ruiz Rde C., Araya J.E., Da Silveira J.F., Yoshida N. Involvement of the stage-specific 82-kilodalton adhesion molecule of Trypanosoma cruzi metacyclic trypomastigotes in host cell invasion. Infect. Immun. 1993, 61:3636-3641.
37. Atayde V.D., Neira I., Cortez M., Ferreira D., Freymuller E., Yoshida N. Molecular basis of non-virulence of Trypanosoma cruzi clone CL-14. Int. J. Parasitol. 2004, 34:851-860.
38. Staquicini D.I., Martins R.M., Macedo S., Sasso G.R., Atayde V.D., Juliano M.A., Yoshida N. Role of GP82 in the selective binding to gastric mucin during oral infection with Trypanosoma cruzi. PLoS Negl. Trop. Dis. 2010, 4:e613.
39. Buscaglia C.A., Campo V.A., Frasch A.C., Di Noia J.M. Trypanosoma cruzi surface mucins: host-dependent coat diversity. Nat. Rev. Microbiol. 2006, 4:229-236.
40. Yoshida N., Mortara R.A., Araguth M.F., Gonzalez J.C., Russo M. Metacyclic neutralizing effect of monoclonal antibody 10D8 directed to the 35- and 50-kilodalton surface glycoconjugates of Trypanosoma cruzi. Infect. Immun. 1989, 57:1663-1667.
41. Alcaide P., Fresno M. AgC10, a mucin from Trypanosoma cruzi, destabilizes TNF and cyclooxygenase-2 mRNA by inhibiting mitogen-activated protein kinase p38. Eur. J. Immunol. 2004, 34:1695-1704.
42. McKerrow J.H., Caffrey C., Kelly B., Loke P., Sajid M. Proteases in parasitic diseases. Annu. Rev. Pathol. 2006, 1:497-536.
43. Sajid M., McKerrow J.H. Cysteine proteases of parasitic organisms. Mol. Biochem. Parasitol. 2002, 120:1-21.
44. Meirelles M.N., Juliano L., Carmona E., Silva S.G., Costa E.M., Murta A.C., Scharfstein J. Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro. Mol. Biochem. Parasitol. 1992, 52:175-184.
45. Alvarez V.E., Niemirowicz G.T., Cazzulo J.J. The peptidases of Trypanosoma cruzi: digestive enzymes, virulence factors, and mediators of autophagy and programmed cell death. Biochim. Biophys. Acta 2012, 1824:195-206.
46. Scharfstein J., Schmitz V., Morandi V., Capella M.M., Lima A.P., Morrot A., Juliano L., Muller-Esterl W. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. J. Exp. Med. 2000, 192:1289-1300.
47. Berasain P., Carmona C., Frangione B., Cazzulo J.J., Goni F. Specific cleavage sites on human IgG subclasses by cruzipain, the major cysteine proteinase from Trypanosoma cruzi. Mol. Biochem. Parasitol. 2003, 130:23-29.
48. Stempin C., Giordanengo L., Gea S., Cerban F. Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen. J. Leukoc. Biol. 2002, 72:727-734.
49. Doyle P.S., Zhou Y.M., Hsieh I., Greenbaum D.C., McKerrow J.H., Engel J.C. The Trypanosoma cruzi protease cruzain mediates immune evasion. PLoS Pathog. 2011, 7:e1002139.
50. Garrido V.V., Dulgerian L.R., Stempin C.C., Cerban F.M. The increase in mannose receptor recycling favors arginase induction and Trypanosoma cruzi survival in macrophages. Int. J. Biol. Sci. 2011, 7:1257-1272.
51. Franke de Cazzulo B.M., Martinez J., North M.J., Coombs G.H., Cazzulo J.J. Effects of proteinase inhibitors on the growth and differentiation of Trypanosoma cruzi. FEMS Microbiol. Lett. 1994, 124:81-86.
52. Tomas A.M., Miles M.A., Kelly J.M. Overexpression of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, is associated with enhanced metacyclogenesis. Eur. J. Biochem. 1997, 244:596-603.
53. Acosta D.M., Arnaiz M.R., Esteva M.I., Barboza M., Stivale D., Orlando U.D., Torres S., Laucella S.A., Couto A.S., Duschak V.G. Sulfates are main targets of immune responses to cruzipain and are involved in heart damage in BALB/c immunized mice. Int. Immunol. 2008, 20:461-470.
54. Burleigh B.A., Andrews N.W. A 120-kDa alkaline peptidase from Trypanosoma cruzi is involved in the generation of a novel Ca(2+)-signaling factor for mammalian cells. J. Biol. Chem. 1995, 270:5172-5180.
55. Burleigh B.A., Caler E.V., Webster P., Andrews N.W. A cytosolic serine endopeptidase from Trypanosoma cruzi is required for the generation of Ca2+ signaling in mammalian cells. J. Cell. Biol. 1997, 136:609-620.
56. Caler E.V., Vaena de Avalos S., Haynes P.A., Andrews N.W., Burleigh B.A. Oligopeptidase B-dependent signaling mediates host cell invasion by Trypanosoma cruzi. EMBO J. 1998, 17:4975-4986.
57. Coetzer T.H., Goldring J.P., Huson L.E. Oligopeptidase B: a processing peptidase involved in pathogenesis. Biochimie 2008, 90:336-344.
58. Swenerton R.K., Zhang S., Sajid M., Medzihradszky K.F., Craik C.S., Kelly B.L., McKerrow J.H. The oligopeptidase B of Leishmania regulates parasite enolase and immune evasion. J. Biol. Chem. 2011, 286:429-440.
59. Bastos I.M., Grellier P., Martins N.F., Cadavid-Restrepo G., de Souza-Ault M.R., Augustyns K., Teixeira A.R., Schrevel J., Maigret B., da Silveira J.F., Santana J.M. Molecular, functional and structural properties of the prolyl oligopeptidase of Trypanosoma cruzi (POP Tc80), which is required for parasite entry into mammalian cells. Biochem. J. 2005, 388:29-38.
60. Alves M.J., Abuin G., Kuwajima V.Y., Colli W. Partial inhibition of trypomastigote entry into cultured mammalian cells by monoclonal antibodies against a surface glycoprotein of Trypanosoma cruzi. Mol. Biochem. Parasitol. 1986, 21:75-82.
61. Giordano R., Fouts D.L., Tewari D., Colli W., Manning J.E., Alves M.J. Cloning of a surface membrane glycoprotein specific for the infective form of Trypanosoma cruzi having adhesive properties to laminin. J. Biol. Chem. 1999, 274:3461-3468.
62. Tonelli R.R., Giordano R.J., Barbu E.M., Torrecilhas A.C., Kobayashi G.S., Langley R.R., Arap W., Pasqualini R., Colli W., Alves M.J. Role of the gp85/trans-sialidases in Trypanosoma cruzi tissue tropism: preferential binding of a conserved peptide motif to the vasculature in vivo. PLoS Negl. Trop. Dis. 2010, 4:e864.
63. Magdesian M.H., Tonelli R.R., Fessel M.R., Silveira M.S., Schumacher R.I., Linden R., Colli W., Alves M.J. A conserved domain of the gp85/trans-sialidase family activates host cell extracellular signal-regulated kinase and facilitates Trypanosoma cruzi infection. Exp. Cell. Res. 2007, 313:210-218.
64. Tonelli R.R., Torrecilhas A.C., Jacysyn J.F., Juliano M.A., Colli W., Alves M.J. In vivo infection by Trypanosoma cruzi: the conserved FLY domain of the gp85/trans-sialidase family potentiates host infection. Parasitology 2011, 138:481-492.
65. Eugenia Giorgi M., de Lederkremer R.M. Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite. Carbohydr. Res. 2011, 346:1389-1393.
66. Schenkman S., Eichinger D., Pereira M.E., Nussenzweig V. Structural and functional properties of Trypanosoma trans-sialidase. Annu. Rev. Microbiol. 1994, 48:499-523.
67. Prioli R.P., Mejia J.S., Pereira M.E. Monoclonal antibodies against Trypanosoma cruzi neuraminidase reveal enzyme polymorphism, recognize a subset of trypomastigotes, and enhance infection in vitro. J. Immunol. 1990, 144:4384-4391.
68. Pereira M.E., Zhang K., Gong Y., Herrera E.M., Ming M. Invasive phenotype of Trypanosoma cruzi restricted to a population expressing trans-sialidase. Infect. Immun. 1996, 64:3884-3892.
69. Schenkman R.P., Vandekerckhove F., Schenkman S. Mammalian cell sialic acid enhances invasion by Trypanosoma cruzi. Infect. Immun. 1993, 61:898-902.
70. Carvalho S.T., Sola-Penna M., Oliveira I.A., Pita S., Goncalves A.S., Neves B.C., Sousa F.R., Freire-de-Lima L., Kurogochi M., Hinou H., Nishimura S., Mendonca-Previato L., Previato J.O., Todeschini A.R. A new class of mechanism-based inhibitors for Trypanosoma cruzi trans-sialidase and their influence on parasite virulence. Glycobiology 2010, 20:1034-1045.
71. Lieke T., Grobe D., Blanchard V., Grunow D., Tauber R., Zimmermann-Kordmann M., Jacobs T., Reutter W. Invasion of Trypanosoma cruzi into host cells is impaired by N-propionylmannosamine and other N-acylmannosamines. Glycoconjugate J. 2011, 28:31-37.
72. Alcantara-Neves N.M., Ribeiro-dos-Santos R., Amor A.L., Uemura H., Silva-Neto S.J., Eichinger D., Pontes-de-Carvalho L. Parasite-derived trans-sialidase binds to heart tissue in Trypanosoma cruzi-infected animals. Microb. Pathog. 2004, 37:273-278.
73. Todeschini A.R., Girard M.F., Wieruszeski J.M., Nunes M.P., DosReis G.A., Mendonca-Previato L., Previato J.O. trans-Sialidase from Trypanosoma cruzi binds host T-lymphocytes in a lectin manner. J. Biol. Chem. 2002, 277:45962-45968.
74. Monteiro V.G., Lobato C.S., Silva A.R., Medina D.V., de Oliveira M.A., Seabra S.H., de Souza W., DaMatta R.A. Increased association of Trypanosoma cruzi with sialoadhesin positive mice macrophages. Parasitol. Res. 2005, 97:380-385.
75. Risso M.G., Garbarino G.B., Mocetti E., Campetella O., Gonzalez Cappa S.M., Buscaglia C.A., Leguizamon M.S. Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages. J. Infect. Dis. 2004, 189:2250-2259.
76. Tibayrenc M. Genetic epidemiology of parasitic protozoa and other infectious agents: the need for an integrated approach. Int. J. Parasitol. 1998, 28:85-104.
77. Rubin S.S., Schenkman S. Trypanosoma cruzi trans-sialidase as a multifunctional enzyme in Chagas' disease. Cell. Microbiol. 2012, [Epub ahead of print].
78. Tribulatti M.V., Mucci J., Van Rooijen N., Leguizamon M.S., Campetella O. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents. Infect. Immun. 2005, 73:201-207.
79. Moreno V.R., Aguero F., Tekiel V., Sanchez D.O. The calcineurin A homologue from Trypanosoma cruzi lacks two important regulatory domains. Acta Trop. 2007, 101:80-89.
80. Araya J.E., Cornejo A., Orrego P.R., Cordero E.M., Cortez M., Olivares H., Neira I., Sagua H., da Silveira J.F., Yoshida N., Gonzalez J. Calcineurin B of the human protozoan parasite Trypanosoma cruzi is involved in cell invasion. Microbes. Infect. 2008, 10:892-900.
81. Naderer T., Dandash O., McConville M.J. Calcineurin is required for Leishmania major stress response pathways and for virulence in the mammalian host. Mol. Microbiol. 2011, 80:471-480.
82. Moro A., Ruiz-Cabello F., Fernandez-Cano A., Stock R.P., Gonzalez A. Secretion by Trypanosoma cruzi of a peptidyl-prolyl cis-trans isomerase involved in cell infection. EMBO J. 1995, 14:2483-2490.
83. Belaunzaran M.L., Lammel E.M., de Isola E.L. Phospholipases a in trypanosomatids. Enzym. Res. 2011, 2011:392082.
84. Cuevas I.C., Cazzulo J.J., Sanchez D.O. gp63 homologues in Trypanosoma cruzi: surface antigens with metalloprotease activity and a possible role in host cell infection. Infect. Immun. 2003, 71:5739-5749.
85. Yao C. Major surface protease of trypanosomatids: one size fits all?. Infect. Immun. 2010, 78:22-31.
86. Hall B.F., Webster P., Ma A.K., Joiner K.A., Andrews N.W. Desialylation of lysosomal membrane glycoproteins by Trypanosoma cruzi: a role for the surface neuraminidase in facilitating parasite entry into the host cell cytoplasm. J. Exp. Med. 1992, 176:313-325.
87. Andrews N.W., Abrams C.K., Slatin S.L., Griffiths G. A T. cruzi-secreted protein immunologically related to the complement component C9: evidence for membrane pore-forming activity at low pH. Cell 1990, 61:1277-1287.
88. Hall B.F., Joiner K.A. Developmentally-regulated virulence factors of Trypanosoma cruzi and their relationship to evasion of host defences. J. Eukaryot. Microbiol. 1993, 40:207-213.
89. Rubin-de-Celis S.S., Uemura H., Yoshida N., Schenkman S. Expression of trypomastigote trans-sialidase in metacyclic forms of Trypanosoma cruzi increases parasite escape from its parasitophorous vacuole. Cell. Microbiol. 2006, 8:1888-1898.
90. Gonzalez J., Ramalho-Pinto F.J., Frevert U., Ghiso J., Tomlinson S., Scharfstein J., Corey E.J., Nussenzweig V. Proteasome activity is required for the stage-specific transformation of a protozoan parasite. J. Exp. Med. 1996, 184:1909-1918.
91. de Diego J.L., Katz J.M., Marshall P., Gutierrez B., Manning J.E., Nussenzweig V., Gonzalez J. The ubiquitin-proteasome pathway plays an essential role in proteolysis during Trypanosoma cruzi remodeling. Biochemistry 2001, 40:1053-1062.
92. Furuya T., Kashuba C., Docampo R., Moreno S.N. A novel phosphatidylinositol-phospholipase C of Trypanosoma cruzi that is lipid modified and activated during trypomastigote to amastigote differentiation. J. Biol. Chem. 2000, 275:6428-6438.
93. Okura M., Fang J., Salto M.L., Singer R.S., Docampo R., Moreno S.N. A lipid-modified phosphoinositide-specific phospholipase C (TcPI-PLC) is involved in differentiation of trypomastigotes to amastigotes of Trypanosoma cruzi. J. Biol. Chem. 2005, 280:16235-16243.
94. de Paulo Martins V., Okura M., Maric D., Engman D.M., Vieira M., Docampo R., Moreno S.N. Acylation-dependent export of Trypanosoma cruzi phosphoinositide-specific phospholipase C to the outer surface of amastigotes. J. Biol. Chem. 2010, 285:30906-30917.
95. Martins Vde P., Galizzi M., Salto M.L., Docampo R., Moreno S.N. Developmental expression of a Trypanosoma cruzi phosphoinositide-specific phospholipase C in amastigotes and stimulation of host phosphoinositide hydrolysis. Infect. Immun. 2010, 78:4206-4212.
96. Gonzalez J., Cornejo A., Santos M.R., Cordero E.M., Gutierrez B., Porcile P., Mortara R.A., Sagua H., Da Silveira J.F., Araya J.E. A novel protein phosphatase 2A (PP2A) is involved in the transformation of human protozoan parasite Trypanosoma cruzi. Biochem. J. 2003, 374:647-656.
97. Lauwaet T., Davids B.J., Torres-Escobar A., Birkeland S.R., Cipriano M.J., Preheim S.P., Palm D., Svard S.G., McArthur A.G., Gillin F.D. Protein phosphatase 2A plays a crucial role in Giardia lamblia differentiation. Mol. Biochem. Parasitol. 2007, 152:80-89.
98. Wiese M. Leishmania MAP kinases-familiar proteins in an unusual context. Int. J. Parasitol. 2007, 37:1053-1062.
99. Madeira da Silva L., Beverley S.M. Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows that TOR3 is required for acidocalcisome biogenesis and animal infectivity. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11965-11970.
100. Nascimento M., Zhang W.W., Ghosh A., Houston D.R., Berghuis A.M., Olivier M., Matlashewski G. Identification and characterization of a protein-tyrosine phosphatase in Leishmania: involvement in virulence. J. Biol. Chem. 2006, 281:36257-36268.
101. Sangenito L.S., Ennes-Vidal V., Marinho F.A., Da Mota F.F., Santos A.L., D'Avila-Levy C.M., Branquinha M.H. Arrested growth of Trypanosoma cruzi by the calpain inhibitor MDL28170 and detection of calpain homologues in epimastigote forms. Parasitology 2009, 136:433-441.
102. Ennes-Vidal V., Menna-Barreto R.F., Santos A.L., Branquinha M.H., D'avila-Levy C.M. Effects of the calpain inhibitor MDL28170 on the clinically relevant forms of Trypanosoma cruzi in vitro. J. Antimicrob. Chemother. 2010, 65:1395-1398.
103. Andrade H.M., Murta S.M., Chapeaurouge A., Perales J., Nirde P., Romanha A.J. Proteomic analysis of Trypanosoma cruzi resistance to Benznidazole. J. Proteome. Res. 2008, 7:2357-2367.
104. Perez Brandan C., Padilla A.M., Xu D., Tarleton R.L., Basombrio M.A. Knockout of the dhfr-ts gene in Trypanosoma cruzi generates attenuated parasites able to confer protection against a virulent challenge. PLoS Negl. Trop. Dis. 2011, 5:e1418.
105. Zago M.P., Barrio A.B., Cardozo R.M., Duffy T., Schijman A.G., Basombrio M.A. Impairment of infectivity and immunoprotective effect of a LYT1 null mutant of Trypanosoma cruzi. Infect. Immun. 2008, 76:443-451.
106. Barrio A.B., Van Voorhis W.C., Basombrio M.A. Trypanosoma cruzi: attenuation of virulence and protective immunogenicity after monoallelic disruption of the cub gene. Exp. Parasitol. 2007, 117:382-389.